LivingGLP1
Study S001433

Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

Registration

Registration
NCT03883412
Acronym
ZQL007
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
NONE
Status
RECRUITING
Enrollment
60
Start
2019-02-28
Primary completion
2027-06
Lead sponsor
University of Virginia
Conditions
Type2 Diabetes
Interventions
OTHER:Exercise; DRUG:Liraglutide
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Microvascular Blood Volume - change from baseline [16 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.